GeneDx Holdings: Unique Genomics Company Focused on Whole Exome and Genome Sequencing

GeneDx is characterized by comprehensive genome and exome tests that utilize a vast genetic database linked to over 400 diseases. The company reduces diagnosis times from years to days, improves patient outcomes, and lowers healthcare costs. The company essentially targets a $45 billion growth market for genetic testing. GeneDx Holdings (NASDAQ: WGS) is a genomics company that performs genome and exome testing. So far, they have built an extensive genetic database linking at least 400 diseases to specific genes. This is important as...